Friday, November 22, 2024
A common warning you’ll hear on Wall Street when a stock is in a major downtrend with no end in sight is not to “catch a falling knife.” This popular investing idiom is often used to describe a risky investment strategy, even if it applies to a bellwether stock. The danger in trying to catch […]
Angenus (AGEN) is a biotech company focused on clinical-stage immuno-oncology, with 17 candidates in development. Nine of those candidates are company owned, while the rest are with partnerships of some well-known drug makers. AGEN also has three experimental vaccines in clinical studies, as well as two adjuvants, which are substances that enhance the body’s immune […]
During the first half of 2021, stocks climbed higher in a very linear fashion. It was a great time to watch your investment account balances, but not so good if you like to “buy the dip,” since there never seemed to be a dip. Now in the waning days of summer, fears of a broader […]
TransMedics (TMDX) is a very interesting company that is reimagining traditional transplant therapy for end-stage organ failure and several diseases. Its Organ Care System (OCS) is a novel concept that works better than current standards as its replicates natural living and functioning of an organ outside of the body. The technology keeps donor organs, such […]
Biogen’s (BIIB) stock price pushed higher this week the U.S. FDA approved its therapy for Alzheimer’s disease. According to CNBC, “The FDA’s decision was highly anticipated as U.S. regulatory approval would make aducanumab the first drug approved to slow cognitive decline in people living with the disease and the first new medicine for Alzheimer’s in […]
Let’s say a successful coronavirus vaccine is created. Great, right? Yes, of course. But it turns out that is the easy part. The truly difficult task—global distribution of the vaccine—will still lie ahead.. The New York Times described it perfectly: “Companies may have to transport tiny glass vials thousands of miles while keeping them as […]
